Guillaume Pfefer, Sail Biomedicines CEO
October 19, 2023 11:33 AM EDTUpdated 01:52 PM
Startups

Up­dat­ed: Flag­ship merges its trou­bled cir­cu­lar RNA com­pa­ny Laronde with nanopar­ti­cle start­up Sen­da

Ryan Cross

Senior Science Correspondent

Laronde and Sen­da Bio­sciences, two biotech star­tups found­ed by Flag­ship Pi­o­neer­ing that col­lec­tive­ly raised more than $750 mil­lion, are merg­ing to form a new com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times